Director, Biomarkers and Precision Medicine
Passage Bio, Inc
Philadelphia, Pennsylvania
Karen J. Quadrini, Ph.D. has over 13 years of industry experience in biomarkers and translational research. She currently serves as Director of Biomarkers and Precision Medicine at Passage Bio, where she is responsible for biomarker strategy and implementation, including assay development and validation, for the company’s gene therapy portfolio for central nervous system disorders. Prior to joining Passage Bio, Dr. Quadrini was a senior scientist in R&D at ICON Laboratory Services where she developed and validated custom flow cytometric and cell-based assays for predominantly first-in-human and phase I-II clinical trials. She started her industry career as a scientist in preclinical and translational research at IRX Therapeutics (now Brooklyn ImmunoTherapeutics). Dr. Quadrini received her Ph.D. in Biomedical Sciences from the Icahn School of Medicine at Mount Sinai, formerly Mount Sinai School of Medicine of New York University (NYC). She is an active volunteer for the American Association of Pharmaceutical Scientists (AAPS) and has been a member of the leadership team for the AAPS Biomarkers and Precision Medicine Community since 2019.
Speaker Spotlight: Single-Cell Multi-Omics for Cell and Gene Therapies
Monday, October 23, 2023
2:30 PM – 3:30 PM ET